Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

Related Citations for PubMed (Select 19828695)

1.

Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality.

Jasperson LK, Bucher C, Panoskaltsis-Mortari A, Mellor AL, Munn DH, Blazar BR.

Blood. 2009 Dec 3;114(24):5062-70. doi: 10.1182/blood-2009-06-227587. Epub 2009 Oct 14.

2.

Granulocyte colony-stimulating factor-induced immature myeloid cells inhibit acute graft-versus-host disease lethality through an indoleamine dioxygenase-independent mechanism.

Joo YD, Lee SM, Lee SW, Lee WS, Lee SM, Park JK, Choi IW, Park SG, Choi I, Seo SK.

Immunology. 2009 Sep;128(1 Suppl):e632-40. doi: 10.1111/j.1365-2567.2009.03048.x. Epub 2009 Jan 12.

3.

Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality.

Jasperson LK, Bucher C, Panoskaltsis-Mortari A, Taylor PA, Mellor AL, Munn DH, Blazar BR.

Blood. 2008 Mar 15;111(6):3257-65. Epub 2007 Dec 12.

4.

Suppression of acute graft-versus-host response by TCDD is independent of the CTLA-4-IFN-γ-IDO pathway.

Rohlman D, Punj S, Pennington J, Bradford S, Kerkvliet NI.

Toxicol Sci. 2013 Sep;135(1):81-90. doi: 10.1093/toxsci/kft140. Epub 2013 Jun 23.

5.

GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

Munn DH, Sharma MD, Baban B, Harding HP, Zhang Y, Ron D, Mellor AL.

Immunity. 2005 May;22(5):633-42.

6.

Immuno-regulatory function of indoleamine 2,3 dioxygenase through modulation of innate immune responses.

Poormasjedi-Meibod MS, Jalili RB, Hosseini-Tabatabaei A, Hartwell R, Ghahary A.

PLoS One. 2013 Aug 5;8(8):e71044. doi: 10.1371/journal.pone.0071044. Print 2013.

7.

Allostimulatory activity of bone marrow-derived plasmacytoid dendritic cells is independent of indoleamine dioxygenase but regulated by inducible costimulator ligand expression.

Colvin BL, Sumpter TL, Tokita D, Salati J, Mellor AL, Thomson AW.

Hum Immunol. 2009 May;70(5):313-20. doi: 10.1016/j.humimm.2009.01.021. Epub 2009 Feb 3.

8.

IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity.

Lu Y, Giver CR, Sharma A, Li JM, Darlak KA, Owens LM, Roback JD, Galipeau J, Waller EK.

Blood. 2012 Jan 26;119(4):1075-85. doi: 10.1182/blood-2010-12-322891. Epub 2011 Nov 30.

10.

Tryptophan metabolite 3-hydroxyanthranilic acid selectively induces activated T cell death via intracellular GSH depletion.

Lee SM, Lee YS, Choi JH, Park SG, Choi IW, Joo YD, Lee WS, Lee JN, Choi I, Seo SK.

Immunol Lett. 2010 Aug 16;132(1-2):53-60. doi: 10.1016/j.imlet.2010.05.008. Epub 2010 Jun 4.

PMID:
20570696
11.

High expression of IMPACT protein promotes resistance to indoleamine 2,3-dioxygenase-induced cell death.

Habibi D, Jalili RB, Forouzandeh F, Ong CJ, Ghahary A.

J Cell Physiol. 2010 Oct;225(1):196-205. doi: 10.1002/jcp.22220.

PMID:
20648630
12.

Airway epithelial indoleamine 2,3-dioxygenase inhibits CD4+ T cells during Aspergillus fumigatus antigen exposure.

Paveglio SA, Allard J, Foster Hodgkins SR, Ather JL, Bevelander M, Campbell JM, Whittaker LeClair LA, McCarthy SM, van der Vliet A, Suratt BT, Boyson JE, Uematsu S, Akira S, Poynter ME.

Am J Respir Cell Mol Biol. 2011 Jan;44(1):11-23. doi: 10.1165/rcmb.2009-0167OC. Epub 2010 Jan 29.

13.

Inhibition of allogeneic T-cell response by Kupffer cells expressing indoleamine 2,3-dioxygenase.

Yan ML, Wang YD, Tian YF, Lai ZD, Yan LN.

World J Gastroenterol. 2010 Feb 7;16(5):636-40.

14.

Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice.

Reddy P, Sun Y, Toubai T, Duran-Struuck R, Clouthier SG, Weisiger E, Maeda Y, Tawara I, Krijanovski O, Gatza E, Liu C, Malter C, Mascagni P, Dinarello CA, Ferrara JL.

J Clin Invest. 2008 Jul;118(7):2562-73. doi: 10.1172/JCI34712.

15.

Implications of IFN-gamma-mediated tryptophan catabolism on solid organ transplantation.

Brandacher G, Margreiter R, Fuchs D.

Curr Drug Metab. 2007 Apr;8(3):273-82. Review.

PMID:
17430115
16.

CDllc+ cells modulate pulmonary immune responses by production of indoleamine 2,3-dioxygenase.

Swanson KA, Zheng Y, Heidler KM, Mizobuchi T, Wilkes DS.

Am J Respir Cell Mol Biol. 2004 Mar;30(3):311-8. Epub 2003 Sep 4.

PMID:
12959949
17.

IFN-γ receptor-deficient donor T cells mediate protection from graft-versus-host disease and preserve graft-versus-tumor responses after allogeneic bone marrow transplantation.

Sun K, Hsiao HH, Li M, Ames E, Bouchlaka M, Welniak LA, Hagino T, Jagdeo J, Pai CC, Chen M, Blazar BR, Abedi M, Murphy WJ.

J Immunol. 2012 Aug 15;189(4):2033-42. doi: 10.4049/jimmunol.1102853. Epub 2012 Jul 9.

18.

Central role of IFNgamma-indoleamine 2,3-dioxygenase axis in regulation of interleukin-12-mediated antitumor immunity.

Gu T, Rowswell-Turner RB, Kilinc MO, Egilmez NK.

Cancer Res. 2010 Jan 1;70(1):129-38. doi: 10.1158/0008-5472.CAN-09-3170. Epub 2009 Dec 22.

19.

Indoleamine 2,3-dioxygenase gene transfer prolongs cardiac allograft survival.

Li J, Meinhardt A, Roehrich ME, Golshayan D, Dudler J, Pagnotta M, Trucco M, Vassalli G.

Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3415-23. Epub 2007 Oct 12.

20.

Tryptophan catabolism is associated with acute GVHD after human allogeneic stem cell transplantation and indicates activation of indoleamine 2,3-dioxygenase.

Landfried K, Zhu W, Waldhier MC, Schulz U, Ammer J, Holler B, Wolff D, Edinger M, Peter K, Kreutz M, Andreesen R, Oefner PJ, Holler E.

Blood. 2011 Dec 22;118(26):6971-4. doi: 10.1182/blood-2011-06-357814. Epub 2011 Oct 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk